BPC-157

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid pentadecapeptide described in the literature as a partial sequence derived from a protein found in gastric juice, which is why it is often called a stable gastric pentadecapeptide. VANTA supplies it strictly as a reference compound for laboratory research.

VANTA supplies BPC-157 as a lyophilized powder. Each lot is assessed by reversed-phase HPLC to quantify chromatographic purity and confirmed by mass spectrometry for identity, so researchers can attribute results to the peptide rather than to contaminants. The verified specification is documented on every batch COA.

The sealed lyophilized vial is generally stored at -20 C and protected from light. Researchers typically reconstitute with an appropriate solvent immediately before use per their own institutional protocols, then store the reconstituted material at 2-8 C and use it within about 30 days. These are reference notes for laboratory handling only.

Yes. Every lot of BPC-157 ships with a per-batch Certificate of Analysis documenting the HPLC purity result, the mass-spec identity confirmation, and lot-level details. This per-lot documentation lets a laboratory tie each experiment to a specific, traceable batch and its analytical record.

In preclinical and in-vitro literature, BPC-157 has been examined in models of tendon, ligament, and muscle repair, gastrointestinal mucosal integrity, angiogenesis, and brain-gut axis signaling, including reported interactions with the nitric oxide and eNOS pathway. These are model-specific observations reported by investigators, not established outcomes.

No. BPC-157 supplied by VANTA is strictly for laboratory and research use only. It is not approved or labeled for human consumption, clinical use, diagnostic procedures, or as a therapeutic agent. Referenced studies were conducted in animal or in-vitro models and do not establish safety or effect in humans.